NCT02551718
- Conditions
- Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +17 more
- Locations
-
- Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States
Clinical trial condition
Recurrent Acute Leukemia of Ambiguous Lineage
Explore clinical trials studying Recurrent Acute Leukemia of Ambiguous Lineage. Study availability and eligibility vary by location and protocol.
2 public trials
0 recruiting studies
Recurrent Acute Leukemia of Ambiguous Lineage trial results
Active, Not Recruiting
A Study of Revumenib in Combination With Chemotherapy for Patients Diagnosed With Relapsed or Refractory Leukemia
NCT05761171
- Conditions
- Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +21 more
- Locations
-
- Children's Hospital of Alabama Birmingham, Alabama, United States
- Arkansas Children's Hospital Little Rock, Arkansas, United States
- Kaiser Permanente Downey Medical Center Downey, California, United States
- Loma Linda University Medical Center Loma Linda, California, United States